ID

39028

Description

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics; ODM derived from: https://clinicaltrials.gov/show/NCT01654120

Link

https://clinicaltrials.gov/show/NCT01654120

Keywords

Versions (1)
  1. 11/22/19 11/22/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 22, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type II NCT01654120

English

Eligibility Diabetes Mellitus, Type II NCT01654120

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male and female patients with type 2 diabetes with hba1c from 6.5 to 10% treated with intensive insulin therapy (mdi or csii, including u-500 insulin-treated patients) using > 100 units of insulin, with or without a stable dose of oral insulin sensitizing medications, for at least three months.
Description

Gender | Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Insulin regime With intensity | Insulin injection Daily Dose Multiple | Continuous subcutaneous infusion of insulin | Humulin insulin | Insulin U/day Quantity | Other Coding

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0011860
UMLS CUI [3]
C0474680
UMLS CUI [4,1]
C0557978
UMLS CUI [4,2]
C0522510
UMLS CUI [5,1]
C0199782
UMLS CUI [5,2]
C2348070
UMLS CUI [5,3]
C0439064
UMLS CUI [6]
C0393124
UMLS CUI [7]
C0020171
UMLS CUI [8,1]
C0021641
UMLS CUI [8,2]
C0456683
UMLS CUI [8,3]
C1265611
UMLS CUI [9]
C3846158
2. aged 18 to 80 years.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
3. females of child-bearing potential must be using adequate form of contraception.
Description

Childbearing Potential Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
4. patient willing to monitor bg four times daily, use cgm, and comply with study-related protocol.
Description

Blood Glucose Self-Monitoring times/day | Continuous glucose monitoring | Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0005803
UMLS CUI [1,2]
C0439511
UMLS CUI [2]
C4523945
UMLS CUI [3]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. type 1 diabetes.
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
2. use of any glp-1 receptor agonist within previous three months.
Description

GLP-1 Receptor Agonist

Data type

boolean

Alias
UMLS CUI [1]
C2917359
3. use of dpp-4 inhibitors or oral insulin secretagogues within the previous three months.
Description

Dipeptidyl Peptidase 4 Inhibitors | Pills Releasing Insulin

Data type

boolean

Alias
UMLS CUI [1]
C2917254
UMLS CUI [2,1]
C0994475
UMLS CUI [2,2]
C1283071
UMLS CUI [2,3]
C0021641
4. use of glucocorticoids (except inhaled).
Description

Glucocorticoids | Exception Glucocorticoids by Inhalation

Data type

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017710
UMLS CUI [2,3]
C0205535
5. use of any experimental drug within previous three months.
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
6. known or suspected allergy to liraglutide, novolog or levemir.
Description

Hypersensitivity Liraglutide | Hypersensitivity NovoLog | Hypersensitivity Levemir | Hypersensitivity Suspected Liraglutide | Hypersensitivity Suspected NovoLog | Hypersensitivity Suspected Levemir

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1456408
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0939412
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C1314782
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C1456408
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0750491
UMLS CUI [5,3]
C0939412
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0750491
UMLS CUI [6,3]
C1314782
7. personal or family history of medullary carcinoma of the thyroid or men-2.
Description

Medullary carcinoma of thyroid | Familial medullary thyroid carcinoma | Multiple Endocrine Neoplasia Type | Family history of multiple endocrine neoplasia Type

Data type

boolean

Alias
UMLS CUI [1]
C0238462
UMLS CUI [2]
C1833921
UMLS CUI [3,1]
C0027662
UMLS CUI [3,2]
C0332307
UMLS CUI [4,1]
C4039247
UMLS CUI [4,2]
C0332307
8. concomitant chronic renal disease with creatinine > 1.5%.
Description

Chronic Kidney Disease | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C1561643
UMLS CUI [2]
C0201976
9. concomitant chronic hepatic, gastrointestinal or other illness (including pancreatitis or active cardiovascular disease except stable exertional angina).
Description

Chronic liver disease | Gastrointestinal Disease chronic | Chronic disease | Pancreatitis | Cardiovascular Disease | Exception Exercise-induced angina Stable

Data type

boolean

Alias
UMLS CUI [1]
C0341439
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0008679
UMLS CUI [4]
C0030305
UMLS CUI [5]
C0007222
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0577698
UMLS CUI [6,3]
C0205360
10. inability or unwillingness to monitor bg, use cgm, or comply with study protocol.
Description

Blood Glucose Self-Monitoring Unable | Continuous glucose monitoring Unable | Protocol Compliance Unable | Blood Glucose Self-Monitoring Unwilling | Continuous glucose monitoring Unwilling | Protocol Compliance Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C0005803
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C4523945
UMLS CUI [2,2]
C1299582
UMLS CUI [3,1]
C0525058
UMLS CUI [3,2]
C1299582
UMLS CUI [4,1]
C0005803
UMLS CUI [4,2]
C0558080
UMLS CUI [5,1]
C4523945
UMLS CUI [5,2]
C0558080
UMLS CUI [6,1]
C0525058
UMLS CUI [6,2]
C0558080
11. women of child-bearing potential unwilling to use adequate contraception, intending to become pregnant or breast-feeding.
Description

Childbearing Potential Contraceptive methods Unwilling | Pregnancy intended | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C1283828
UMLS CUI [3]
C0006147
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus, Type II NCT01654120

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement | Insulin regime With intensity | Insulin injection Daily Dose Multiple | Continuous subcutaneous infusion of insulin | Humulin insulin | Insulin U/day Quantity | Other Coding
Item
1. male and female patients with type 2 diabetes with hba1c from 6.5 to 10% treated with intensive insulin therapy (mdi or csii, including u-500 insulin-treated patients) using > 100 units of insulin, with or without a stable dose of oral insulin sensitizing medications, for at least three months.
boolean
C0079399 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0474680 (UMLS CUI [3])
C0557978 (UMLS CUI [4,1])
C0522510 (UMLS CUI [4,2])
C0199782 (UMLS CUI [5,1])
C2348070 (UMLS CUI [5,2])
C0439064 (UMLS CUI [5,3])
C0393124 (UMLS CUI [6])
C0020171 (UMLS CUI [7])
C0021641 (UMLS CUI [8,1])
C0456683 (UMLS CUI [8,2])
C1265611 (UMLS CUI [8,3])
C3846158 (UMLS CUI [9])
Age
Item
2. aged 18 to 80 years.
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Contraceptive methods
Item
3. females of child-bearing potential must be using adequate form of contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Blood Glucose Self-Monitoring times/day | Continuous glucose monitoring | Protocol Compliance
Item
4. patient willing to monitor bg four times daily, use cgm, and comply with study-related protocol.
boolean
C0005803 (UMLS CUI [1,1])
C0439511 (UMLS CUI [1,2])
C4523945 (UMLS CUI [2])
C0525058 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
1. type 1 diabetes.
boolean
C0011854 (UMLS CUI [1])
GLP-1 Receptor Agonist
Item
2. use of any glp-1 receptor agonist within previous three months.
boolean
C2917359 (UMLS CUI [1])
Dipeptidyl Peptidase 4 Inhibitors | Pills Releasing Insulin
Item
3. use of dpp-4 inhibitors or oral insulin secretagogues within the previous three months.
boolean
C2917254 (UMLS CUI [1])
C0994475 (UMLS CUI [2,1])
C1283071 (UMLS CUI [2,2])
C0021641 (UMLS CUI [2,3])
Glucocorticoids | Exception Glucocorticoids by Inhalation
Item
4. use of glucocorticoids (except inhaled).
boolean
C0017710 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017710 (UMLS CUI [2,2])
C0205535 (UMLS CUI [2,3])
Investigational New Drugs
Item
5. use of any experimental drug within previous three months.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Liraglutide | Hypersensitivity NovoLog | Hypersensitivity Levemir | Hypersensitivity Suspected Liraglutide | Hypersensitivity Suspected NovoLog | Hypersensitivity Suspected Levemir
Item
6. known or suspected allergy to liraglutide, novolog or levemir.
boolean
C0020517 (UMLS CUI [1,1])
C1456408 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0939412 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C1314782 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C1456408 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C0750491 (UMLS CUI [5,2])
C0939412 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
C1314782 (UMLS CUI [6,3])
Medullary carcinoma of thyroid | Familial medullary thyroid carcinoma | Multiple Endocrine Neoplasia Type | Family history of multiple endocrine neoplasia Type
Item
7. personal or family history of medullary carcinoma of the thyroid or men-2.
boolean
C0238462 (UMLS CUI [1])
C1833921 (UMLS CUI [2])
C0027662 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C4039247 (UMLS CUI [4,1])
C0332307 (UMLS CUI [4,2])
Chronic Kidney Disease | Creatinine measurement, serum
Item
8. concomitant chronic renal disease with creatinine > 1.5%.
boolean
C1561643 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Chronic liver disease | Gastrointestinal Disease chronic | Chronic disease | Pancreatitis | Cardiovascular Disease | Exception Exercise-induced angina Stable
Item
9. concomitant chronic hepatic, gastrointestinal or other illness (including pancreatitis or active cardiovascular disease except stable exertional angina).
boolean
C0341439 (UMLS CUI [1])
C0017178 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0008679 (UMLS CUI [3])
C0030305 (UMLS CUI [4])
C0007222 (UMLS CUI [5])
C1705847 (UMLS CUI [6,1])
C0577698 (UMLS CUI [6,2])
C0205360 (UMLS CUI [6,3])
Blood Glucose Self-Monitoring Unable | Continuous glucose monitoring Unable | Protocol Compliance Unable | Blood Glucose Self-Monitoring Unwilling | Continuous glucose monitoring Unwilling | Protocol Compliance Unwilling
Item
10. inability or unwillingness to monitor bg, use cgm, or comply with study protocol.
boolean
C0005803 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C4523945 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C0525058 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
C0005803 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
C4523945 (UMLS CUI [5,1])
C0558080 (UMLS CUI [5,2])
C0525058 (UMLS CUI [6,1])
C0558080 (UMLS CUI [6,2])
Childbearing Potential Contraceptive methods Unwilling | Pregnancy intended | Breast Feeding
Item
11. women of child-bearing potential unwilling to use adequate contraception, intending to become pregnant or breast-feeding.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0032961 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial